– CBL-0201DD Phase 2 study met the primary and all secondary endpoints. – 64.5% of painful lipomas showed complete clearance or dimensions reduction of more than 50% after CBL-514 treatments. – 54.8% of painful lipomas showed complete clearance or dimension reduction of more than 50%…